CONNECT WITH US
HealthTech

HealthTech

AstraZeneca’s bruising summer raises the stakes for 2027

Endpoints News logo

Published on

Add as a preferred source on Google
AstraZeneca’s bruising summer raises the stakes for 2027

When one of As­traZeneca’s med­i­cines, Wain­ua, failed a ma­jor late-stage heart dis­ease tri­al in Ju­ly, it was a jar­ring set­back for a drug­mak­er whose re­search …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

FDA charts path for ap­proval of in­di­vid­u­al­ized gene edit­ing ther­a­pies October 28, 2026

Den­mark's Gubra looks be­yond me­tab­o­lism, hopes for first port­fo­lio com­pa­ny this year October 27, 2026

Fer­ring to ac­quire ovary-in-a-dish start­up Ga­me­to for up to $1.38B October 27, 2026

An­throp­ic's lat­est biotech buy is a one-man stealth start­up run by a pseu­do­ny­mous Twit­ter poster

Cit­ing 'safe­ty' and 'free­dom,' HHS will al­low com­pound­ing of cer­tain well­ness pep­tides

Backed by Amish and Men­non­ites, a new kind of gene ther­a­py com­pa­ny takes shape



Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.